TARDBP and amyotrophic lateral sclerosis: Interestingly, both TDP-43 pathology and TDP-43-negative but ubiquitin-positive inclusions have been often reported in C9-ALS patients, further indicating defects in transmembrane transport and protein degradation in carriers of C9orf72 repeat expansions.82